[Can HIV infection be competitively inhibited? New therapeutic approaches--development of an immuno-adhesin].
Hentze
S
S
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000627:therapeutic use*; D001667:Binding, Competitive / Q000187:drug effects; D015699:HIV Envelope Protein gp120; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D015728:Receptors, HIV; D011991:Receptors, Virus / Q000187:drug effects*; D012191:Retroviridae Proteins
D000945:Antigens, Differentiation, T-Lymphocyte; D015699:HIV Envelope Protein gp120; D015728:Receptors, HIV; D011991:Receptors, Virus; D012191:Retroviridae Proteins
HIV-Infektion kompetitiv hemmbar? Neue therapeutische Ansätze--Entwicklung eines Immunoadhäsins.